Sign in

Coronary artery disease: trials that stopped early

Trials on Coronary artery disease that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

96 stopped trials give a reason in the registry, latest registry update first. 1 more gives no reason and is not listed.

  1. Withdrawn

    The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease

    Reason given in the registry

    “This study will be revived with retrospective design.”

    Quoted unchanged from ClinicalTrials.gov; record updated 23 Jul 2021.

    Ended
    Dec 2023
    Run by
    Jung-min Ahn
    Registry record
    NCT02981134
  2. Withdrawn

    Impact of a Digital Solution (CardiCare™) on Cardiorespiratory Fitness Improvement in Patients Discharged From a Phase 2 Cardiac Rehabilitation Following an Acute Coronary Syndrome

    Reason given in the registry

    “Study suspended due to the COVID-19 pandemic. Some study procedures are not curently possible for many investigational sites.”

    Quoted unchanged from ClinicalTrials.gov; record updated 29 Jun 2021.

    Ended
    Dec 2023
    Run by
    Ad scientiam
    Registry record
    NCT04294940
  3. Withdrawn

    Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery

    Reason given in the registry

    “Closure due to lack of funding.”

    Quoted unchanged from ClinicalTrials.gov; record updated 27 Jan 2021.

    Phase
    Phase 1/2
    Run by
    Weill Medical College of Cornell University
    Registry record
    NCT01757223
  4. Withdrawn

    The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

    Reason given in the registry

    “Study has never enrolled any subjects”

    Quoted unchanged from ClinicalTrials.gov; record updated 22 Oct 2020.

    Phase
    Phase 1/2
    Run by
    Joshua M Hare
    Registry record
    NCT02503280
  5. Withdrawn

    IRIS-Firehawk® Cohort in the IRIS-DES Registry

    Reason given in the registry

    “Funding issue”

    Quoted unchanged from ClinicalTrials.gov; record updated 9 Mar 2018.

    Ended
    Dec 2025
    Run by
    Duk-Woo Park, MD
    Registry record
    NCT03380286
  6. Withdrawn

    Statin Therapy In Patients With Vasospastic Angina

    Reason given in the registry

    “Funding issue”

    Quoted unchanged from ClinicalTrials.gov; record updated 15 Jun 2017.

    Ended
    Dec 2023
    Phase
    Phase 4
    Run by
    Seung-Jung Park
    Registry record
    NCT02790528

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.